StockData
Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc. (CADL) stock

CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$5.40−0.41 (-7.06%)

Close on Nov 17, 2026Market cap $413.20MP/E –Yield –

Candel Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Candel Therapeutics's operating margin for the twelve months ending Dec 31, 2022 was -27777.6%. For fiscal 2022 it was -27777.6%, against -20580.8% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-27777.6%−7196.8
FY2021Dec 31, 2021-20580.8%−9532.8
FY2020Dec 31, 2020-11048.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2022Dec 31, 2022-26132.3%−1164.5
Q3 FY2022Sep 30, 2022-28648.4%−2748.4
Q2 FY2022Jun 30, 2022-28235.5%−11135.5
Q1 FY2022Mar 31, 2022-28987.1%−13964.5
Q4 FY2021Dec 31, 2021-24967.7%−5209.7
Q3 FY2021Sep 30, 2021-25900.0%−17032.3
Q2 FY2021Jun 30, 2021-17100.0%−8651.6
Q1 FY2021Mar 31, 2021-15022.6%–
Q4 FY2020Dec 31, 2020-19758.1%–
Q3 FY2020Sep 30, 2020-8867.7%–
Q2 FY2020Jun 30, 2020-8448.4%–

More Candel Therapeutics figures

See a number that looks wrong?